Chronic Kidney Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who received at least one dose of a medicine called vonsetamig as part of a previous clinical trial (NCT05092347, also called study R5459-RT-1944)
- People who received a kidney transplant during that previous trial, after a compatibility matching process was completed
- People who are willing and able to attend clinic visits and follow the study procedures
- People who have signed a consent form agreeing to take part, either themselves or through a legally recognised representative
Who may not be able to join:
- There are no official exclusion criteria listed for this trial — the trial site will be able to confirm whether a person meets the requirements
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Clinical Trial Management, Regeneron Pharmaceuticals
Phone: 844-734-6643
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Incidence of Adverse Events; Incidence of Serious Adverse Events
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.